Chris Poll

Background

About Chris Poll

Energetic, professional and self motivated, a confident and innovative scientific leader with over 28 years experience in drug discovery with pharma and biotech companies in the areas of respiratory disease, inflammation and immunology research, and a proven track record in setting and rapidly achieving goals through the motivation and development of others. Career summary - Over 28 years research and leadership experience in drug discovery with pharma and biotech companies (Glaxo, Sandoz, Bayer, Novartis, hVIVO) in the areas of respiratory disease, inflammation and immunology research - Led the Novartis respiratory pharmacology team that generated preclinical data packages to support progression of inhaled long acting bronchodilators Onbrez and Seebri into and through the clinic to market and QVA149 to EMA filing - Led Novartis COPD and CF international programme that delivered 8 candidate molecules (low molecular weight and biologics) for clinical proof of concept studies - Successfully championed the introduction of Cystic Fibrosis as a disease indication and led the setting up of CF preclinical research within Novartis - Track record of successful multidisciplinary international project/programme leadership of teams of up to 70 members - Line management experience of leading drug discovery and clinical science teams of up to 50 members - Strong track record in the initiation, review and management of key international and UK collaborations with academic groups and companies/CROs for drug discovery, preclinical and early development activities Specialities Drug discovery; respiratory diseases; COPD; Cystic Fibrosis; asthma; infectious diseases; inflammation; immunology; pharmaceutical industry; translational science; clinical research; pharmacology; biochemistry; portfolio management; project management; assay development; respiratory model development; new target identification and validation; biomarker discovery and validation